Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

oligoastrocytoma (MOA) - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

oligoastrocytoma

MONDO:0016702

Also known as:MOAWHO grade II mixed gliomaglioma, mixed, benign

Find Clinical TrialsTrials

Overview

A WHO grade II tumor composed of a conspicuous mixture of two distinct neoplastic cell types morphologically resembling the tumor cells in oligodendroglioma and diffuse astrocytoma. (WHO)

Clinical Trials6 registered · 1 recruiting

Diagnosis

Biomarker and diagnostic research for oligoastrocytoma has been reported in the published literature.

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

6 clinical trials registered, 1 recruiting. Interventions under study include drug therapy, procedural interventions, other interventions, and biologic therapy. Pipeline includes 3 PHASE2, 3 PHASE1. Research is primarily sponsored by academic and government institutions.

NCT ID	Title	Phase	Sponsor	Status
[NCT02800486](https://clinicaltrials.gov/study/NCT02800486)

Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 3:38 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

Orphanet

European rare disease database

Orphanet:251656

GARD

Genetic and Rare Diseases Info Center

GARD:9769

Questions for Your Care Team

→Are any of the 6 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

Research Type	Count	% of Total
Research summaries	65	30%
Patient case studies	39	18%
Laboratory research	35	16%
Testing and diagnosis research	34	16%
Disease patterns and progression	23	11%
Clinical study results	12	6%
New treatment approaches	6	3%
Other research	4	2%

oligoastrocytoma

Overview

Diagnosis

Research Landscape

Medical References

External Resources

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Recent Publications